These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19300884)

  • 1. Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience.
    Saumier D; Aisen PS; Gauthier S; Vellas B; Ferris SH; Duong A; Suhy J; Oh J; Lau W; Garceau D; Haine D; Sampalis J
    J Nutr Health Aging; 2009 Apr; 13(4):370-2. PubMed ID: 19300884
    [No Abstract]   [Full Text] [Related]  

  • 2. Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study.
    Saumier D; Duong A; Haine D; Garceau D; Sampalis J
    J Nutr Health Aging; 2009 Nov; 13(9):808-12. PubMed ID: 19812871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.
    Gauthier S; Aisen PS; Ferris SH; Saumier D; Duong A; Haine D; Garceau D; Suhy J; Oh J; Lau W; Sampalis J
    J Nutr Health Aging; 2009 Jun; 13(6):550-7. PubMed ID: 19536424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Effects of Oral Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification.
    Sabbagh MN
    J Prev Alzheimers Dis; 2017; 4(3):136-137. PubMed ID: 29182703
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
    Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
    J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies for Alzheimer's disease.
    Melnikova I
    Nat Rev Drug Discov; 2007 May; 6(5):341-2. PubMed ID: 17539055
    [No Abstract]   [Full Text] [Related]  

  • 7. Tramiprosate.
    Wright TM
    Drugs Today (Barc); 2006 May; 42(5):291-8. PubMed ID: 16801992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease.
    Hey JA; Yu JY; Versavel M; Abushakra S; Kocis P; Power A; Kaplan PL; Amedio J; Tolar M
    Clin Pharmacokinet; 2018 Mar; 57(3):315-333. PubMed ID: 29063518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain.
    Hey JA; Kocis P; Hort J; Abushakra S; Power A; Vyhnálek M; Yu JY; Tolar M
    CNS Drugs; 2018 Sep; 32(9):849-861. PubMed ID: 30076539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis.
    Gervais F; Paquette J; Morissette C; Krzywkowski P; Yu M; Azzi M; Lacombe D; Kong X; Aman A; Laurin J; Szarek WA; Tremblay P
    Neurobiol Aging; 2007 Apr; 28(4):537-47. PubMed ID: 16675063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2 study of tramiprosate for cerebral amyloid angiopathy.
    Greenberg SM; Rosand J; Schneider AT; Creed Pettigrew L; Gandy SE; Rovner B; Fitzsimmons BF; Smith EE; Edip Gurol M; Schwab K; Laurin J; Garceau D
    Alzheimer Dis Assoc Disord; 2006; 20(4):269-74. PubMed ID: 17132972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
    Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzhemed: a potential treatment for Alzheimer's disease.
    Aisen PS; Gauthier S; Vellas B; Briand R; Saumier D; Laurin J; Garceau D
    Curr Alzheimer Res; 2007 Sep; 4(4):473-8. PubMed ID: 17908052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study.
    Martens RM; Bechten A; Ingala S; van Schijndel RA; Machado VB; de Jong MC; Sanchez E; Purcell D; Arrighi MH; Brashear RH; Wattjes MP; Barkhof F
    Eur Radiol; 2018 Mar; 28(3):1215-1226. PubMed ID: 28956123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors.
    Aisen PS
    CNS Drugs; 2005; 19(12):989-96. PubMed ID: 16332141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and Function of Alzheimer's Amyloid βeta Proteins from Monomer to Fibrils: A Mini Review.
    Agrawal N; Skelton AA
    Protein J; 2019 Aug; 38(4):425-434. PubMed ID: 31325011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
    Sur C; Kost J; Scott D; Adamczuk K; Fox NC; Cummings JL; Tariot PN; Aisen PS; Vellas B; Voss T; Mahoney E; Mukai Y; Kennedy ME; Lines C; Michelson D; Egan MF
    Brain; 2020 Dec; 143(12):3816-3826. PubMed ID: 33253354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).
    Aisen PS; Gauthier S; Ferris SH; Saumier D; Haine D; Garceau D; Duong A; Suhy J; Oh J; Lau WC; Sampalis J
    Arch Med Sci; 2011 Feb; 7(1):102-11. PubMed ID: 22291741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Inhibitory Effect of GQDs-Tramiprosate Covalent Binding on Amyloid Aggregation.
    Liu Y; Xu LP; Wang Q; Yang B; Zhang X
    ACS Chem Neurosci; 2018 Apr; 9(4):817-823. PubMed ID: 29244487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.